134 related articles for article (PubMed ID: 32106138)
1. Case Report of Probable Duloxetine-Induced Hyperosmia.
Gündoğmuş İ; Ünsal C; Taşci AB; Uçar H; Bolu A; Öznur T; Özmenler KN
Clin Neuropharmacol; 2020; 43(2):54. PubMed ID: 32106138
[No Abstract] [Full Text] [Related]
2. Dysosmia and dysgeusia associated with duloxetine.
Yoshida K; Fukuchi T; Sugawara H
BMJ Case Rep; 2017 Nov; 2017():. PubMed ID: 29170185
[TBL] [Abstract][Full Text] [Related]
3. Duloxetine-induced rapid eye movement sleep behavior disorder: a case report.
Tan L; Zhou J; Yang L; Ren R; Zhang Y; Li T; Tang X
BMC Psychiatry; 2017 Nov; 17(1):372. PubMed ID: 29162053
[TBL] [Abstract][Full Text] [Related]
4. Hyponatremia Induced by Duloxetine: A Case Report.
Hu D; Wurster S
Consult Pharm; 2018 Aug; 33(8):446-449. PubMed ID: 30068437
[TBL] [Abstract][Full Text] [Related]
5. [Duloxetine-Induced Hypertension: A Case Report].
Mermi O; Atmaca M
Turk Psikiyatri Derg; 2016; 27(1):67-9. PubMed ID: 27369688
[TBL] [Abstract][Full Text] [Related]
6. Probable Galactorrhea Associated with Sequential Trials of Escitalopram and Duloxetine in an Adolescent Female.
McGrane IR; Morefield CM; Aytes KL
J Child Adolesc Psychopharmacol; 2019 Dec; 29(10):788-789. PubMed ID: 31339744
[No Abstract] [Full Text] [Related]
7. Acute Hyponatremia Resulting from Duloxetine-induced Syndrome of Inappropriate Antidiuretic Hormone Secretion.
Yoshida K; Aburakawa Y; Suzuki Y; Kuroda K; Kimura T
Intern Med; 2019 Jul; 58(13):1939-1942. PubMed ID: 30799365
[TBL] [Abstract][Full Text] [Related]
8. Hepatic outcomes among adults taking duloxetine: a retrospective cohort study in a US health care claims database.
Lin ND; Norman H; Regev A; Perahia DG; Li H; Chang CL; Dore DD
BMC Gastroenterol; 2015 Oct; 15():134. PubMed ID: 26467777
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and adverse events of selective serotonin noradrenaline reuptake inhibitors in the management of postoperative pain: A systematic review and meta-analysis.
Schnabel A; Weibel S; Reichl SU; Meißner M; Kranke P; Zahn PK; Pogatzki-Zahn EM; Meyer-Frießem CH
J Clin Anesth; 2021 Dec; 75():110451. PubMed ID: 34311244
[TBL] [Abstract][Full Text] [Related]
10. A probable case of movement disorder (Tardive dyskinesia) due to duloxetine treatment.
Yılmaz R; Üstün D; Tuncer Uzun S; Reisli R; Türk Ş
Agri; 2018 Oct; 30(4):199-201. PubMed ID: 30403275
[TBL] [Abstract][Full Text] [Related]
11. Antidepressants May Make for Depressing Surgery.
Oberg TJ; Eftekhari K; Anderson RL
Ophthalmic Plast Reconstr Surg; 2015; 31(4):334. PubMed ID: 26164037
[No Abstract] [Full Text] [Related]
12. Syndrome of inappropriate antidiuretic hormone secretion: a story of duloxetine-induced hyponatraemia.
Amoako AO; Brown C; Riley T
BMJ Case Rep; 2015 Apr; 2015():. PubMed ID: 25911354
[TBL] [Abstract][Full Text] [Related]
13. [Duloxetine Associated Galactorrhea and Hyperprolactinemia: A Case Report].
Özkan HM
Turk Psikiyatri Derg; 2020; 31(4):294-296. PubMed ID: 33454942
[TBL] [Abstract][Full Text] [Related]
14. Upper gastrointestinal bleeding due to overdose of selective serotonin reuptake inhibitors and nonsteroidal anti-inflammatory drugs.
Sanz Segura P; García Cámara P; Gotor Delso J; Monzón Báez RM; Llorente Barrio M; Fernández Bonilla E; Bernal Monterde V
Gastroenterol Hepatol; 2019 Dec; 42(10):622-623. PubMed ID: 31324464
[No Abstract] [Full Text] [Related]
15. Duloxetine-Associated Acute Laryngeal Dystonia: A Case Report.
Dagklis IE; Rokkou I; Kazis D; Bostantjopoulou S
J Clin Psychopharmacol; 2019; 39(6):678-679. PubMed ID: 31688398
[No Abstract] [Full Text] [Related]
16. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, may be a double-edged sword for patients with advanced Parkinson's disease.
Nagamine T
Asian J Psychiatr; 2020 Apr; 50():102031. PubMed ID: 32272360
[No Abstract] [Full Text] [Related]
17. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
[TBL] [Abstract][Full Text] [Related]
18. [Serotonin syndrome associated with the administration of duloxetine; report of a case].
Fernández Fernández R; Fernández Alonso E; Castro Rebollo P; Soy Muner D
Farm Hosp; 2016 May; 40(3):225-6. PubMed ID: 27145391
[No Abstract] [Full Text] [Related]
19. Cervical Spinal Cord Stimulation with Concomitant Serotonin Norepinephrine Reuptake Inhibitor Therapy Leading to the Serotonin Syndrome.
Dizdarevic A; Bremer N
Pain Med; 2017 Jun; 18(6):1199-1202. PubMed ID: 28057811
[No Abstract] [Full Text] [Related]
20. A randomized, placebo-controlled study of duloxetine for the treatment of children and adolescents with generalized anxiety disorder.
Strawn JR; Prakash A; Zhang Q; Pangallo BA; Stroud CE; Cai N; Findling RL
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):283-93. PubMed ID: 25791145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
